Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases
Clinical Trials: Asthma
A listing of clinical trials currently looking for volunteers to enroll in Asthma studies. Click on the closest city to find more detailed information on a research study in your area.
Birmingham :
A Non-drug Study Profiling Asthma
Birmingham : University of Alabama at Birmingham Lung Health Center
Bronchial Thermoplasty in Severe Persistent Asthma
Birmingham : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Birmingham : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Mobile : Pulmonary Associates of Mobile P.C.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Phoenix : Phoenix Children's Hospital
A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children
Scottsdale : Teva Investigational Site 10104 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Scottsdale : Allergy & Immunology Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tucson : University of Arizona
Diagnosis of Exercise-Induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes
Huntington Park : Rx for Life, Inc.
Are you African-American? Do you have Asthma?
Los Angeles : California Allergy and Asthma Medical Group, Inc.
Do you have asthma?
Los Angeles : MCS Clinical Trials
Randomized, Double-Blind, Placebo controlled Phase II Study to examine the effects of DAS181in healthy adult subjects with confirmed laboratory influenza.
Rolling Hills Estates : Peninsula Research Associates, Inc.
Do you have asthma?
Rolling Hills Estates : Peninsula Research Associates, Inc.
Do you or your child suffer from asthma?
View More »
Anaheim : Investigational Site Number 840047
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Bakersfield : Teva Investigational Site 10173 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Buena Park : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Costa Mesa : Amphastar Site 5
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Costa Mesa : West Coast Clinical Trials
Safety Study in Adolescent and Adult Patients With Asthma
Cypress : West Coast Clinical Trials, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Encinitas : Teva Investigational Site 10156 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Encinitas : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Fountain Valley : Investigational Site Number 840043
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Fresno : Research Center of Fresno Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Fresno : Research Center of Fresno
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Fullerton : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Huntington Beach : Teva Investigational Site 10157 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Huntington Beach : Teva Investigational Site 10176 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Huntington Beach : Pediatric Care Medical Group
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Huntington Beach : 205.418.01020 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Huntington Beach : GSK Investigational Site
Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study
Long Beach : Allergy & Asthma Care Center of Southern California
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Long Beach : Teva Investigational Site 10147 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Long Beach : West Coast Clinical Trials
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Long Beach : Investigational Site Number 840046
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Long Beach : Health Care Partners Medical Group
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Long Beach : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Los Angeles : GSK Investigational Site
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Los Angeles : Allergy Medical Clinic, Research Division
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Los Angeles : California Allergy and Asthma Medical Group Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Los Angeles : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Los Angeles : Investigational Site Number 840032
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Los Angeles : Investigational Site Number 840036
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Los Angeles : 205.419.01058 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Los Angeles : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Los Angeles : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Los Angeles : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Los Angeles : Southern California Institute for Respiratory Diseases, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
Los Angeles : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Mission Viejo : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Mission Viejo : Southern California Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mission Viejo : Investigational Site Number 840005
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Mission Viejo : 205.418.01002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Mission Viejo : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Newport Beach : Teva Investigational Site 10136 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Orange : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Orange : Clinical Trials of Orange County, Inc.
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Orange : Teva Investigational Site 10140 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Orange : Choc Pediatric Subspecialty Faculty
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Orange : Clinical Trials of Orange County, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Orange : Investigational Site Number 840007
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Orange : Investigational Site Number 840033
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Orange : Amphastar Site 8
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Orange : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Orange : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Orange : CHOC PSF, AMD, Division of Allergy, Asthma and Immunology
Safety Study in Adolescent and Adult Patients With Asthma
Orange : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Palmdal : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Palmdale : California Allergy and Asthma Medical Group Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Rancho Mirage : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Redwood : Allergy and Asthma Consultants
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Riverside : Teva Investigational Site 10143 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Riverside : Investigational Site Number 840048
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Riverside : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rolling Hills Estate : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Rolling Hills Estates : Investigational Site Number 840035
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Sacramento : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
San Diego : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
San Diego : Teva Investigational Site 10130 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Diego : Allergy & Asthma Medical Group & Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Diego : Institute of Healthcare Assessment Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Diego : 205.418.01014 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
San Diego : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
San Diego : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
San Diego : UCSD Medical Center
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
San Diego : UCSD Medical Center - Thornton Hospital
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
San Diego : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
San Francisco : University of California San Francisco
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
San Francisco : University of California - San Francisco
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Francisco : Investigational Site Number 840041
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
San Francisco : Investigational Site Number 840042
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
San Francisco : Ovation Research Group
Impact of Asthma Treatments on Daily Activities
San Jose : Teva Investigational Site 10179 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Jose : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
San Jose : Investigational Site Number 840039
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
San Jose : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
San Jose : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
San Jose : Allergy & Asthma Associates of Santa Clara Valley Research Center
Safety Study in Adolescent and Adult Patients With Asthma
San Mateo : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Santa Rosa : Investigational Site Number 840024
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
South San Francisco : Genentech Trial Information Support Line
An Observational Study of the Use and Safety of Xolair During Pregnancy
Stockton : Teva Investigational Site 10106 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Stockton : Investigational Site Number 840002
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Stockton : Amphastar Site 4
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Stockton : 205.419.01053 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Stockton : Bensch Research Associates
Safety Study in Adolescent and Adult Patients With Asthma
Stockton : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Sylmar : Olive View - UCLA Medical Center
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Vista : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Walnut Creek : Allergy & Asthma Clinical Research, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Walnut Creek : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Centennial : 1st International Clinical Research Center
Is your asthma uncontrolled?
View More »
Centennial : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Centennial : IMMUNOe International Research Centers
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Centennial : 205.419.01061 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Colorado Springs : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Colorado Springs : Teva Investigational Site 10172 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Colorado Springs : Asthma And Allergy Associates, P.C.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Storms Clinical Research Institute
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Asthma & Allergy Associates P.C.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Vectura Clinical Trial Site 10001
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Colorado Springs : Investigational Site Number 840031
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Colorado Springs : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Denver : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Denver : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Denver : National Jewish Medical and Research Center
Cell Biology of Steroid Resistant Asthma
Denver : Investigational Site Number 840017
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Denver : 205.419.01066 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Denver : National Jewish Health
Markers of Airway Inflammation in BAL Fluid From Children With Asthma
Denver : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Denver : Colorado Allergy and Asthma Centers, P.C.
Safety Study in Adolescent and Adult Patients With Asthma
Denver : National Jewish Health
Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma
Denver : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Engelwood : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Lakewood : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Wheat Ridge : Teva Investigational Site 10128 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Wheat Ridge : 205.418.01011 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Wheat Ridge : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Wheat Ridge : Rocky Mountain Center for Clinical Research
Safety Study in Adolescent and Adult Patients With Asthma
Waterbury : Biomedical Research Alliance of New York
Asthma
View More »
New Haven :
A Non-drug Study Profiling Asthma
New Haven : Yale University Center for Asthma and Airway Disease
Bronchial Thermoplasty in Severe Persistent Asthma
New Haven : Investigational Site Number 840026
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
New Haven, : Yale Medical School
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Waterbury : Waterbury Pulmonary Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Waterbury : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Panama City : Emerald Coast Research Associates
Research study for Asthma
View More »
Aventura : Teva Investigational Site 10137 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Aventura : Teva Investigational Site 10153 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Clearwater : Innovative Research of West Florida
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Clearwater : Saint Francis Sleep Allergy and Lung Institute
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Clearwater : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Clearwater : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Clearwater : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Cocoa : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Debary : Omega Research Consultants LLC
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Fort Walton Beach : All Seasons Allergy and Asthma Center, P.A.
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Hialeah : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Jacksonville : Nemours Children's Clinic
Genotype Stratified Pharmacokinetic Study of Montelukast
Jacksonville : Nemours Children's Clinic
Transporter Mediated Uptake of Montelukast
Kissimmee : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Miami : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Miami : Community Research Foundation
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Florida Center for Allergy and Asthma Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Kendall South Medical Center, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Pulmonary Human Research Laboratory, University of Miami, Miller School of Medicine
Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide
Miami : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Ocala : Teva Investigational Site 10171 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Orange City : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Orlando : GSK Investigational Site
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Panama City : 205.419.01064 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Port Charlotte : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sarasota : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Sarasota : Teva Investigational Site 10178 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sarasota : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
South Miami :
AMG 761 in Adults With Asthma
South Miami : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tallahassee : Allergy And Asthma Dtc
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tallahassee : Investigational Site Number 840044
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Tallahassee : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Tallehassee : Teva Investigational Site 10161 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Tampa : Investigational Site Number 840029
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Tampa : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tampa : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Valrico : Brandon - Valrico Center for Allergy and Asthma Research, LLC
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Valrico : Brandon - Valrico Center for Allergy and Asthma Research LL
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Valrico : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
West Palm Beach : Palm Beach Research Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Winter Park : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Winter Park : 205.419.01060 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Atlanta : Pinnacle Trials, Inc.
Do you have both Diabetes & Asthma?
Lawrenceville : DataQuest Medical Research, LLC
Adult Asthma Study for African American Patients
View More »
Albany : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Albany : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Columbus : Brookstone Centre Parkway
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Columbus : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Gainesville : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Lawrenceville : Teva Investigational Site 10168 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Lawrenceville : DataQuest Medical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lilburn : Allergy and Asthma Consultants PC Laboratory
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lilburn : Allergy and Asthma Consultants PC Laboratory
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Savannah : Aeroallergy Research Labs Of Savannah, Inc
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Savannah : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Savannah : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Stockbridge : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Coeur d'Alene : 205.418.01004 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Couer D'Alene : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Meridian : Teva Investigational Site 10116 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Chicago : Rush University Medical Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Chicago : University of Chicago
Bronchial Thermoplasty in Severe Persistent Asthma
Chicago : Rush University Medical Center
Coping Peer Intervention for Adherence
Chicago : Cedar-Crosse Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Chicago : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
DeKalb : Northern Illinois Research Associates
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Elk Grove Village : Central DuPage Hospital
Bronchial Thermoplasty in Severe Persistent Asthma
Hinsdale : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Maywood : Loyola University Medical Center
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Normal : Sneeze, Wheeze & Itch Associates, LLC
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Normal : 205.418.01017 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Normal : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
River Forest : Asthma & Allergy Center of Chicago
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
River Forest : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Skokie : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Springfield : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Evansville : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Indianapolis : Investigational Site Number 840028
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Indianapolis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Albany : Nassim, McMonigle, Mescia & Associates
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
South Bend : Teva Investigational Site 10127 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
South Bend : 205.418.01008 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Iowa City :
A Non-drug Study Profiling Asthma
Iowa City : University of Iowa Hospitals and Clinics
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Iowa City : Iowa Clinical Research Corporation
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Iowa City : University of Iowa
Bronchial Thermoplasty in Severe Persistent Asthma
Iowa City : Investigational Site Number 840038
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
View More »
Iowa City : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Iowa City : Iowa Clinical Research Corportation
Safety Study in Adolescent and Adult Patients With Asthma
Overland Park : Investigational Site Number 840021
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Topeka : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Lexington : University of Kentucky Chandler Medical Center
Assessment of Breathing in Individuals With Vocal Cord Dysfunction
Lexington : University of Kentucky Chandler Medical Center
Asthma Volunteers Needed for Research Study
View More »
Louisville : Family Allergy and Asthma Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Louisville : Kosair Children's Hospital
Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma
Louisville : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Owensboro : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Metairie : Teva Investigational Site 10113 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Metairie : Clinical Research Specialists
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Metairie : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Metairie : Vectura Clinical Trial Site 10002
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Metairie : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
View More »
Metairie : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Metarie : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sunset : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Bangor : Teva Investigational Site 10164 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bangor : Paul Shapero's Private Practice
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bangor : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Baltimore : Johns Hopkins Asthma and Allergy Center
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
Baltimore :
A Non-drug Study Profiling Asthma
Baltimore : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Baltimore : Johns Hopkins Asthma and Allergy Center
Effect of Anti-IgE in Non-Allergic Asthma
Baltimore : Investigational Site Number 840014
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
View More »
Baltimore : 205.418.01012 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Baltimore : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Baltimore : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Bethesda : NIH Clinical Center
A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Bethesda : Teva Investigational Site 10158 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bethesda : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Bethesda : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Boston : St. Elizabeth's Medical Center
Bronchial Thermoplasty in Severe Persistent Asthma
Burlington : Lahey Clinic
Bronchial Thermoplasty in Severe Persistent Asthma
Newton : Newton - Wellesley Hospital
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
North Dartmouth : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
North Dartmouth : Teva Investigational Site 10138 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
North Dartmouth : Teva Investigational Site 10146 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
North Dartmouth : Investigational Site Number 840015
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
North Dartmouth : 205.418.01013 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
North Dartmouth : 205.418.01015 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
North Dartmouth : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
North Dartmouth : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
North Dartmouth : Northeast Medical Research Associates, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
Springfield : Baystate Medical Center
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Ann Arbor : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Ann Arbor : University of Michigan
Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity
Detroit : Henry Ford Hospital
Bronchial Thermoplasty in Severe Persistent Asthma
Grand Blanc : Grand Blanc Medical
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Grand Rapids : Spectrum Health Hospitals
Bronchial Thermoplasty in Severe Persistent Asthma
View More »
Novi : 205.419.01068 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Minneapolis : Clinical Research Institute, MN
ADOLESCENT ASTHMA RESEARCH STUDY_678
Minneapolis : Clinical Research Institute, MN
ADULT ASTHMA RESEARCH STUDY_659
Minneapolis : Clinical Research Institute, MN
Adult Asthma Research Study_707
Minneapolis : Clinical Research Institute, MN
Asthma Research Study for Adolescents & Adults_712
View More »
Byron : Olmstead Medical Center Byron
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Chatfield : Olmstead Medical Center Chatfield
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Minneapolis : Investigational Site Number 840003
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Minneapolis : Investigational Site Number 840010
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Minneapolis : 205.418.01009 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Minneapolis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Minneapolis : Clinical Research Institute, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
Minneapolis : Hennepin County Medical Center
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Pine Island : Olmstead Medical Center Pine Island
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Plainview : Olmstead Medical Center Plainview
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Plymouth : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Plymouth : Teva Investigational Site 10131 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Plymouth : 205.444.01004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Plymouth : 205.419.01054 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Plymouth : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Plymouth : Clinical Research Institute, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
Preston : Olmstead Medical Center Preston
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Rochester : Research site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Rochester : Olmstead Medical Center - Allergy Department
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Rochester : Olmstead Medical Center - Family Medicine Department
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Rochester : Olmstead Medical Center Northwest
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Rochester : Olmsted Medical Center - Internal Medicine Department
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Rochester : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Spring Valley : Olmstead Medical Center Spring Valley
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
St. Charles : Olmstead Medical Center St. Charles
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
St. Paul : HealthPartners Specialty Center, Lung and Sleep Health
Bronchial Thermoplasty in Severe Persistent Asthma
Stewartville : Olmstead Medical Center Stewartville
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Wanamingo : Olmstead Medical Center Wanamingo
Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms
Creve Coeur : The Clinical Research Center, LLC
Asthmatics, do you use a maintenance inhaler on a daily basis? Have you taken Prednisone in the past 12 months to treat your asthma? If so, you may qualify for an asthma research study.
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
A Washington University asthma study seeks volunteers 12 - 75 years of age.
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
A Washington University asthma study seeks volunteers that take Advair or Symbicort for their asthma.
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Asthma patients! Do you use controller medications to treat your asthma?
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Female Asthmatics! Washington University seeks female asthmatics for a research study looking at the effects of an asthma medication!
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have a runny, stuffy nose or sinus infection or inflammation?
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have asthma? Are you interested in taking Vitamin D?
Saint Louis : Washington University in St. Louis - Center for Clinical Studies Updated New
Do you use Xolair to treat your asthma?
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Soy study seeks volunteers with poorly controlled asthma.
St Louis : The Clinical Research Center, LLC
Asthma research study for those currently using Symbicort 160/4.5 or equivalent that continue to experience on-going asthma symptoms.
St Louis : Washington University in St. Louis - Center for Clinical Studies
Asthma Study Seeks Volunteers!
St Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Asthmatics! Washington University seeks asthmatics for a research study using an add-on treatment study medication.
St Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Asthmatics! Washington University seeks participants for a research study on severe asthma.
St Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have asthma?
St Louis : Washington University in St. Louis - Center for Clinical Studies
Do you use daily inhaled corticosteroids?
St. Louis : Midwest Clinical Research LLC
Asthma Clinical Trial
St. Louis : Radiant Research - St. Louis
Clinical Research Study for Asthma
St. Louis : The Clinical Research Center, LLC
Have you been using Advair or Symbicort for 12 months for asthma? Have you experienced at least 2 asthma exacerbations in the last 12 months? If so, you may qualify for an asthma research study.
View More »
Bridgeton : Craig A. Spiegel MD
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Columbia : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Columbia : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Columbia : 205.444.01005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Kansas City : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Ozark : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rolla : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
saint Louis : Washington University School of Medicine
Costimulation Inhibition in Asthma
St Louis : Investigational Site Number 840006
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
St Louis : Investigational Site Number 840013
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
St. Louis : Teva Investigational Site 10175 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
St. Louis : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
St. Louis : Washington University School of Medicine
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
St. Louis : The Clinical Research Center L.L.C.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
St. Louis : Washington University School of Medicine
Bronchial Thermoplasty in Severe Persistent Asthma
St. Louis : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
St. Louis : 205.419.01062 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
St. Louis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
St. Louis : The Clinical Research Center, LLC
Safety Study in Adolescent and Adult Patients With Asthma
St. Louis : Washington University School of Medicine
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
St. Louis : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Warrensburg : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Missoula : Montana Medical Research, Inc.
Have you been diagnosed with Asthma?
View More »
Billings : Billings Clinic Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Bozeman : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bozeman : Investigational Site Number 840022
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Bozeman : 205.419.01070 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Bozeman : Clinical Research Group of Montana
Safety Study in Adolescent and Adult Patients With Asthma
Missoula : Montana Medical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bellevue : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bellevue : Teva Investigational Site 10118 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bellevue : 205.418.01006 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Bellevue : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bellevue : The Asthma & Allergy Center, PC
Safety Study in Adolescent and Adult Patients With Asthma
View More »
Bellevue : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Boys Town : Boys Town National Research Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Boys Town : 205.418.01016 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Omaha : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Omaha : Creighton University Medical Center (CUMC) (Saint Joseph Hospital)
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Omaha : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Omaha : Teva Investigational Site 10150 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Omaha : Midwest Allergy and Asthma Clinic
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Omaha : Investigational Site Number 840025
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Omaha : 205.418.01003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Omaha : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Omaha : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Papillion : Investigational Site Number 840008
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Las Vegas : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Las Vegas : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Brick : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Brick : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Cedar Knolls : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Hackensack : Hackensack University Medical Center
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Hillsborough : Teva Investigational Site 10101 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
Ocean : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Princeton : Investigational Site Number 840018
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Skillman : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Skillman : 205.419.01067 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Skillman : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Skillman : Princeton Center for Clinical Research
Safety Study in Adolescent and Adult Patients With Asthma
Summit : Pulmonary & Allergy Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Summit : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Teaneck : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Albuquerque : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bronx : Biomedical Research Alliance of New York
Asthma
Bronx : Biomedical Research Alliance of New York
Asthma
Bronx : Biomedical Research Alliance of New York
Asthma
New Hyde Park : Biomedical Research Alliance of New York, LLC
Symbicort treatment for patients with asthma
New York : Biomedical Research Alliance of New York, LLC
Symbicort treatment for patients with asthma
Rochester : AAIR Research Center
Have You Been Diagnosed with Asthma?
Rochester : AAIR Research Center
Seeking Volunteers with Asthma for an Investigational New Research Study
Rochester : AAIR Research Center
Study to compare the safety and effectiveness of Symbicort delivered via two different inhalers and Budesonide. The two inhalers are a breath actuated metered dose inhaler and a pressurized metered dose inhaler.
View More »
Albany : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Bronx : Bronx Medical Center for Pulmonary Asthma and Sleep Disorder
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Brooklyn : Maimonides Medical Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Great Neck : North Shore-Long Island Jewish Health System, Division of Allergy/Immunology
The Effect of Montelukast on Asthma Control in Obese Asthmatic Children and Adolescents
Mineola : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Hyde Park : North Shore Diabetes and Endocrine Associates
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York : Columbia University
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
New York : MedHex Health
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Newburgh : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
North Syracuse : Teva Investigational Site 10167 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
North Syracuse : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Rochester : AAIR Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Rochester : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Rochester : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rochester : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Utica : St. Elizabeth Health Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Chapel Hill : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Chapel Hill : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Durham : Duke University
Bronchial Thermoplasty in Severe Persistent Asthma
High Point : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
High Point : Teva Investigational Site 10105 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
High Point : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Morrisville : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Raleigh : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Raleigh : Teva Investigational Site 10122 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Raleigh : 205.419.01071 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Raleigh : Novartis Investigative site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Raleigh : North Carolina Clinical Research
Safety Study in Adolescent and Adult Patients With Asthma
Winston Salem : Investigational Site Number 840004
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Winston-Salem : Wake Forest University Health Sciences
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Winston-Salem : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Winston-Salem : 205.418.01021 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Winston-Salem : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Fargo : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Akron : Radiant Research - Akron
Clinical Research for Asthma
View More »
Akron : Akron General Medical Center
Bronchial Thermoplasty in Severe Persistent Asthma
Canton : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Canton : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Cincinnati : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Cincinnati : Cincinnati Children's Hospital Medical Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Cincinnati : Teva Investigational Site 10123 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Cincinnati : New Horizons Clinical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Cincinnati : Bernstein Clinical Research Center Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Cincinnati : New Horizons Clinical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Cincinnati : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Cincinnati : 205.444.01001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Cincinnati : 205.419.01055 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Cincinnati : New Horiznons Clinical Research
Safety Study in Adolescent and Adult Patients With Asthma
Cincinnati : University of Cincinnati
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Cincinnati : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Cleveland :
A Non-drug Study Profiling Asthma
Cleveland : MetroHealth Medical Center
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
Cleveland : Cleveland Clinic Foundation
Bronchial Thermoplasty in Severe Persistent Asthma
Cleveland : The Cleveland Clinic
Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing
Columbus : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Columbus : Optimed Research LTD
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Columbus : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Columbus : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Dayton : Dayton Clinical Research
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Dublin : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Marion : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sylvania : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Sylvania : Toledo Center for Clinical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Sylvania : Investigational Site Number 840023
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Sylvania : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sylvania : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Norman : Ekips Technologies, Inc.
Development of a Breath Analyzer for Asthma Screening
Oklahoma City : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Oklahoma City : Allergy, Asthma and clinical Research Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Oklahoma City : Eminence Research, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Oklahoma City : Teva Investigational Site 10129 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
Oklahoma City : Teva Investigational Site 10160 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Oklahoma City : Allergy Asthma & Clinical Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Oklahoma City : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Oklahoma City : Investigational Site Number 840045
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Oklahoma City : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Oklahoma City : 205.418.01018 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Oklahoma City : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Oklahoma City : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Oklahoma City : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Ashland : Integrated Medical Research, PC
Safety Study in Adolescent and Adult Patients With Asthma
Eugene : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Eugene : Teva Investigational Site 10132 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Eugene : Allergy and Asthma Research Group
Safety Study in Adolescent and Adult Patients With Asthma
Lake Oswego : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
View More »
Lake Oswego : Investigational Site Number 840001
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Lake Oswego : Baker Allergy, Asthma and Dermatology Research Center, LLC
Safety Study in Adolescent and Adult Patients With Asthma
Medford : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Medford : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Medford : Clinical Research Institute of Southern Oregon, PC
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Medford : Investigational Site Number 840012
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Medford : Amphastar Site 2
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Medford : The Clinical Research Institute of Southern Oregon, PC
Safety Study in Adolescent and Adult Patients With Asthma
Portland : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Portland : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Portland : Teva Investigational Site 10142 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Portland : Investigational Site Number 840016
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Portland : Amphastar Site 1
Evaluation of Efficacy and Safety of E004 in Children With Asthma
Portland : 205.419.01065 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Portland : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Portland : Allergy Associates Research Center
Safety Study in Adolescent and Adult Patients With Asthma
Portland : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Blue Bell : Allergy & Asthma Specialists, P.C.
Currently enrolling asthmatics that are not well controlled on current asthma therapy.
Pittsburgh : Primary Physicians Research
Intermittent and Daily Treatment for Episodic Asthma
View More »
Altoona : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Altoona : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Altoona : Central PA Asthma and Allergy Care LLC
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Blue Bell : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Blue Bell : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Blue Bell : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Hershey : Investigational Site Number 840040
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Philadelphia :
A Non-drug Study Profiling Asthma
Philadelphia : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Philadelphia : University of Pennsylvania
Bronchial Thermoplasty in Severe Persistent Asthma
Philadelphia : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Philadelphia : Albert Einstein Healthcare Network
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Pittsburg : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Pittsburgh : Investigational Site Number 840037
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Pittsburgh : University of Pittsburgh
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
Pittsburgh : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Pittsburgh : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Upland : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Upland : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Upland : Asthma and Allergy Research Associates
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Upland : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Upland : Teva Investigational Site 10121 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Upland : Investigational Site Number 840009
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Lincoln : Teva Investigational Site 10181 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Lincoln : Asthma & Allergy Physicians of Rhode Island Clinical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lincoln : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Lincoln : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Providence : Teva Investigational Site 10162 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
Providence : Asthma, Nasal Disease & Allergy Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Providence : Rhode Island Hospital
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Greer : Radiant Research - Greer
Asthma Research Study
View More »
Charleston : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Charleston : AAC Research - PC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Charleston : National Allergy, Asthma, and Uticaria Centers
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Charleston : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Charleston : Teva Investigational Site 10126 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charleston : Teva Investigational Site 10148 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charleston : Teva Investigational Site 10149 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charleston : Asthma & Allergy Consultants, LLP
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Charleston : Medical University of South Carolina
Bronchial Thermoplasty in Severe Persistent Asthma
Charleston : 205.444.01002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Charleston : Investigational Site Number 840027
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Charleston : 205.418.01005 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Easely : 205.418.01010 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Fort Mill : Piedmont Research Partners LLC
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Greenville : ADAC Research, PA
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Greenville : 205.419.01069 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Mt. Pleasant : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
North Charleston : Amphastar Site 7
Evaluation of Efficacy and Safety of E004 in Children With Asthma
North Charleston : National Allergy, Asthma and Urticaria Centers of Charleston, P.A.
Safety Study in Adolescent and Adult Patients With Asthma
Orangeburg : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Spartanburg : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Spartanburg : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Union : 205.419.01056 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Chattanooga : The Asthma Institute, PLLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Kingsport : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Dallas : Pharmaceutical Research & Consulting, Inc.
Do you have asthma?
Dallas : ACRC TRIALS
DO YOU HAVE ASTHMA?
Plano : ACRC TRIALS
Attention Asthma Sufferers!
Are you a female that suffers from Asthma?
San Antonio : Women's Diagnostics
Clinical research study for patients with Asthma
San Antonio : Diagnostics Research Group
Clinical research study for patients with Asthma
San Antonio : Lung Diagnostics, LTD
Clinical research study for patients with Asthma
San Antonio : Allergy Diagnostics
Clinical research study for patients with Asthma
San Antonio : Diagnostics Research Group
Clinical research study for patients with Asthma
San Antonio : Women's Diagnostics
Clinical research study for patients with Asthma
San Antonio : Lung Diagnostics, LTD
Clinical research study for patients with Asthma
San Antonio : Allergy Diagnostics
Clinical research study for patients with Asthma
San Antonio : Lung Diagnostics
Clinical research study for patients with Moderate-Severe Asthma
Waco : Allergy Asthma Research Institute
A randomized, double-blind with open-lable active comparator, parallel group, multi-center study to evaluate the safety of once daily fluticasone furoate/XXX inhaled powder for 52 weeks in adult and adolescent subjects with asthma.
Waco : Allergy Asthma Research Institute
Adult Asthma Study
Waco : Allergy Asthma Research Institute
Do you suffer from Asthma?
Waco : Allergy Asthma Research Institute
Infants and toddlers with asthma symptoms (coughing, wheezing, shortness of breath).
Waco : Allergy Asthma Research Institute
Pediatric Asthma Study
View More »
Austin : Isis Clinical Research, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Austin : Sirius Clinical Research, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Benbrook : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Boerne : TTS Research
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Boerne : Teva Investigational Site 10119 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Boerne : Allergy and Asthma Center of Boerne
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Corsicana : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Dallas : Dallas Allergy Immunology Research
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Dallas : Allergy/Immunology Research Center of North Texas
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Dallas : 205.418.01007 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Dallas : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Dallas : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Dallas : University of Texas Southwestern Medical Center
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Denton : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Dickinson : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
El Paso : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
El Paso : Western Sky Medical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
El Paso : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
El Paso : Western Sky Medical Research
Comparing Bronchodilation of Symbicort With and With Out Valved Holding Chamber (Aerochamber Plus)
El Paso : Investigational Site Number 840030
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
El Paso : Amphastar Site 3
Evaluation of Efficacy and Safety of E004 in Children With Asthma
El Paso : 205.419.01063 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
El Paso : Allergy and Asthma Center of El Paso
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
El Paso : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
El Paso : Western Sky Medical Research
Safety Study in Adolescent and Adult Patients With Asthma
Fort Worth : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Fort Worth : North Texas Institute for Clinical Trials
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Fort Worth : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Galveston : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Houston : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Houston : Allergy & Asthma Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Houston : Pioneer Research Solutions Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Houston : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Houston : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Katy : Breath of Life Research Institute
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Killen : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Live Oak : Live Oak Allergy and Asthma Clinic
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
New Braunfels : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Braunfels : Central Texas Health Research
Safety Study in Adolescent and Adult Patients With Asthma
San Antonio : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
San Antonio : Quality Assurance Research Center, Inc.
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
San Antonio : Southwest Allergy and Asthma, P.A.
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
San Antonio : Sylvana Research Associates
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
San Antonio : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
San Antonio : Teva Investigational Site 10115 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Antonio : Alamo Clinical Research Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Southwest Allergy and Asthma Research Center, P. A.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Alamo Clinical Research Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Investigational Site Number 840050
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
San Antonio : SAM Clinical Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
San Antonio : Amphastar Site 6
Evaluation of Efficacy and Safety of E004 in Children With Asthma
San Antonio : 205.419.01051 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
San Antonio : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
San Antonio : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
San Antonio : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Waco : Allergy & Asthma Care of Waco
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Waco : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Waco : Teva Investigational Site 10103 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Waco : GSK Investigational Site Updated
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Waco : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Waco : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Draper : Vectura Clinical Trial Site 10004
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Colchester : University of Vermont
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
South Burlington : Teva Investigational Site 10134 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
South Burlington : 205.444.01003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
South Burlington : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Richmond : Pulmonary Associates of Richmond, Inc.
Asthma takes the air out of your game.
View More »
Abingdon : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Burke : PI-Coor Clinical Research, LLC
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Burke : Teva Investigational Site 10159 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charlottesville : University of Virginia Medical Center
Bronchial Thermoplasty in Severe Persistent Asthma
Colonial Heights : Colonial Heights Pediatrics
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Norfolk : Sentara General Hospital
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Richmond : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Richmond : Virginia Commonhealth University
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Richmond : Pulmonary Associates of Richmond
Bronchial Thermoplasty in Severe Persistent Asthma
Richmond : Investigational Site Number 840049
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Richmond : Allergy Partners, PA/VA Adult and Pediatric Allergy and Asthma, P.C.
Safety Study in Adolescent and Adult Patients With Asthma
Springfield : Research Site
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Bellingham : Bellingham Asthma, Allergy, & Immunology Clinic
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Kirkland : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Seattle : Investigational Site Number 840020
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Seattle : 205.418.01019 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Seattle : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Seattle : ASTHMA, Inc.
Safety Study in Adolescent and Adult Patients With Asthma
Seattle : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Spokane : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Tacoma : Franciscan Research Center (St. Joseph Medical Center)
Bronchial Thermoplasty in Severe Persistent Asthma
Tacoma : MultiCare Pulmonary Specialists
Bronchial Thermoplasty in Severe Persistent Asthma
Tacoma : Investigational Site Number 840019
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Tacoma : 205.418.01001 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Tacoma : Research Site
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
Tacoma : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Greenfield : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Greenfield : Teva Investigational Site 10170 Updated
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Madison : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Madison : University of Wisconsin-Madison
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Madison : University of Wisconsin
Bronchial Thermoplasty in Severe Persistent Asthma
View More »
Madison : Investigational Site Number 840034
Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Madison : University of Wisconsin Madison Department of Asthma, Allergy and Pulmonary Clinical Research
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
Milwaukee : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Buenos Aires : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Buenos Aires : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Capital Federal : 205.456.54006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Capital Federal : 205.456.54002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Ciudad Autonoma de Buenos Aire : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
View More »
Ciudad Autonoma de Buenos Aires : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Ciudad Autónoma de Buenos Aires : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Corrientes : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Mendoza : 205.456.54005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Mendoza : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Mendoza : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Rosario : Sanatorio Parque de Rosario
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Miguel de Tucumán : 205.456.54004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
San Miguel de Tucumán : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
San Miguel de Tucumán : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
San Miguel de Tucuman - Tucuman : Centro Médico Dra De Salvo
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Santa Fe : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Santa Fe : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Clayton : Monash Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Frankston : Frankston Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Liverpool : Liverpool Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nedlands : Lung Institute of Western Australia Inc
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Brussels : GSK Investigational Site
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
Bruxelles : Hôpital Erasme
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bruxelles : Hôpital Erasme
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bruxelles : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Eupen : Novartis Investigative Site
Efficacy of QAX576 in Asthma
View More »
Gent : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Laeken : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Leuven : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Liège : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Belo Horizonte : Santa Casa de Belo Horizonte
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Belo Horizonte : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Curitiba : Hospital de Clinicas UFPR
A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma
Florianopolis : 205.419.55053 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Florianopolis : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Juiz de Fora : 205.418.55002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Porto Alegre : 205.418.55004 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Porto Alegre : 205.418.55001 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Porto Alegre : 205.418.55005 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Porto Alegre : 205.419.55054 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Porto Alegre : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Porto Alegre : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Porto Alegre - RS : Hospital Moinhos de Vento
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Rio de Janeiro : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rio de Janeiro : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Rio de Janeiro - RJ : 205.418.55003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Salvador : Centro de Referencia em Enfermidades Respiratoria e Alergica
A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma
Salvador : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sao Paulo : 205.419.55055 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Sao Paulo : 205.419.55052 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Sao Paulo : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sao Paulo : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
São Paulo : Stelmach Pesquisa Clinica
A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma
São Paulo : IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada
A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma
Sorocaba : Clinica de Alergia Martti Antila
A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma
7002 : 205.456.35901 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Pleven : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Plovdiv : 205.456.35902 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Ruse : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Sofia : 205.456.35903 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
View More »
Sofia : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Troyan : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Brampton : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Calgary :
A Non-drug Study Profiling Asthma
Calgary : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Calgary : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Calgary : University of Calgary
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Calgary : GSK Investigational Site
Oral GW766944 (Oral CCR3 Antagonist)
Calgary : Research Site
The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen
Edmonton : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Edmonton : University of Alberta Hospital
Tiotropium for Smoking Asthmatics Study
Hamilton : GSK Investigational Site
Oral GW766944 (Oral CCR3 Antagonist)
Hamilton : Research Site
The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen
La Malbaie : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Montreal : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Montreal : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Montreal : GSK Investigational Site
Oral GW766944 (Oral CCR3 Antagonist)
Newmarket : SKDS Research Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Newmarket : SKDS Research Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Niagara Falls : Niagara Clinical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ottawa : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Pointe-Claire : Dynamik Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quebec : Research Site
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Quebec : GSK Investigational Site
Oral GW766944 (Oral CCR3 Antagonist)
Quebec : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Quebec : Research Site
The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen
Quebec City : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Sainte Foy :
A Non-drug Study Profiling Asthma
Saskatoon : Research Site
The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen
Toronto : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Toronto : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Toronto : The Hospital for Sick Children
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
Vancouver :
A Non-drug Study Profiling Asthma
Vancouver : Research Site Updated
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
Windsor : Dr. Anil Dhar Professional Medicine Corporation
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Windsor : Dr. Anil Dhar Professional Medicine Corporation
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Puente Alto - Santiago : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Rancagua : Hospital Regional Rancagua
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : Hospital Roberto del Rio
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : Investigaciones Medicas Tasol
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : 205.444.56002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
View More »
Santiago : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Valdivia : Hospital Base de Valdivia
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Valparaiso : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Viña del Mar : 205.444.56001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Viña del Mar : 205.444.56003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Beijing : Capital Institute of Pediatrics
Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children
Beijing : The Second Artillery General Hospital of PLA
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Beijing : 205.418.86001 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Beijing : 205.418.86007 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Beijing : 205.418.86005 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
View More »
Beijing : 205.418.86012 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Beijing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Beijing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Changchun : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Changsha : 205.418.86014 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Changsha : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Changsha City : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Chengdu : 205.418.86015 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Chengdu : 205.418.86011 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Chengdu : 205.419.86061 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Chengdu : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Chongqing : 205.418.86003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Chongqing : 205.419.86053 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Chongqing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Foshan : The First Affiliated Hospital of Foshan
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guang zhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Guang Zhou City : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Guangzhou : The First Affiliated Hospital of Guangzhou Medical College, Guangzhou Institute of Respiratory Disease
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guangzhou : Guangzhou First Municipal People's Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guangzhou : 205.418.86010 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Guangzhou : 205.419.86056 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Guangzhou : 205.419.86062 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Guangzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Haikou : 205.419.86054 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Haikou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Hangzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Kunming : 205.418.86013 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Kunming : 205.419.86059 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Nanchang : 205.419.86058 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Nanchang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanjing : Zhongda Hospital of Southeast University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Nanjing : 205.419.86064 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Nanjing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanjing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Qingdao : 205.418.86008 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Shanghai : Dongfang Hospital Affiliated to Tongji University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : Zhongshan Hospital affiliated to Fudan University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : Putuo District Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : 205.418.86002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Shanghai : 205.419.86055 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Shanghai : 205.419.86066 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Shanghai : 205.419.86051 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Shanghai : 205.419.86052 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Shanghai : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shanghai : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shengyang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shenyang : The General Hospital of Shenyang Military Region
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shenyang : Shengjing Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shenyang : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
Shenyang : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Shenyang : 205.418.86004 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Shenyang : 205.418.86009 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Shenyang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shijiazhuang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Suzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Wuhan : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Xian : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Xi'An : 205.418.86006 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Xi'An : 205.419.86065 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Xi'An : 205.419.86057 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Xi'an : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Xuzhou : 205.419.86063 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Yangzhou : 205.419.86067 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Yinchuan : 205.419.86068 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Barranquilla : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bogota : Investigational Site 1902
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
Bogota : Fundación Salud Bosque
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bogota : Fundación Salud Bosque
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bogota : 205.419.57051 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
View More »
Bogota : 205.419.57052 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Bogota : 205.419.57053 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Bogota : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bogotá : Fundacion Neumologica Colombiana
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bogotá : Research Site
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
Floridablanca : Fundacion Oftalmologica de Santander Foscal
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Medelin : 205.419.57054 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Boskovice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Breclav : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Brno : HORNMED s.r.o.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Brno : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Brno - Bohunice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Hradec Kralove : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Jablonec nad Nisou : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Jindřichův Hradec : Sdružená pneumologická a anesteziologická ambulance
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Kladno : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Kutna Hora : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Liberec : Krajska nemocnice Liberec
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Liberec : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Most : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Olomouc : Fakultni Nemocnice Olomouc
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Plzen : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Praha : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tabor : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Teplice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Trutnov : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Aarhus C : Research Dept. of Respiratory Medicine, Aarhus University Hospital
Bronchial Challenge Test of Magnesium-treated Asthmatics
Copenhagen : BørneAstmaKlinikken
Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
Copenhagen : Respiratory and Allergy Research Unit, Department of Respiratory Medicine, Bispebjerg Hospital
Elite Sport and Development of Asthma
Hvidovre : Hvidovre Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Aigrefeuille Sur Maine : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Bordeaux Pessac N/A :
A Non-drug Study Profiling Asthma
Brest : CHU Cavale Blanche
Masitinib in Severe Persistent Asthma
Laon : GSK Investigational Site Updated
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
Marseille :
A Non-drug Study Profiling Asthma
View More »
Marseille cedex 20 : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Montpellier : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Paris : Necker Enfants Malades Hospital
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Bad Wörishofen : Praxis Dr. med. Junggeburth
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bamberg : 205.419.49061 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Berlin : Charité - Universitätsmedizin Berlin
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : Klinische Forschung Berlin Mitte GmbH
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
View More »
Berlin : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Berlin : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Berlin : 205.419.49062 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Berlin : 205.419.49063 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Berlin : 205.419.49064 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Berlin : 205.419.49052 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Bochum : 205.425.49005 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Bochum : 205.456.49001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Bonn : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Bretten : Drez. Gelb & Knecht
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Dresden : 205.425.49004 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Elgershausen. Greifenstein : Lungenfachklinik Waldhof Elgershausen
Inhaled Steroids and Control of Severe Asthma
Frankfurt :
A Non-drug Study Profiling Asthma
Frankfurt : IKF Pneumologie
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Frankfurt : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Frankfurt : 205.456.49004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Frankfurt : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Frankfurt : 205.419.49054 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Frankfurt am Main : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Giessen : Justus-Liebig-University Giessen
Inhaled Steroids and Control of Severe Asthma
Grosshansdorf : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Hamburg : 205.419.49058 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Kassel : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Koblenz : 205.425.49002 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Koblenz : 205.456.49003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Koblenz : 205.419.49057 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Landsberg : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Leipzig : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Lubeck : KLB
Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
Lübeck :
A Non-drug Study Profiling Asthma
Lübeck : 205.419.49056 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Magdeburg : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Mainz : Studienzentrum Mainz Mitte am GesundheitsCentrum Mainz
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mainz : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Mannheim : CRS Clinical Research Services Mannheim GmbH
Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects
Rosenheim : 205.425.49003 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Rostock : Universitätsklinikum Rostock, Abteilung für Pneumologie Zentrum für Innere Medizin, Ernst Heydemann Strasse 6
House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
Rüdersdorf : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Rüdersdorf : Novartis Investigative Site
Efficacy of QAX576 in Asthma
Rüdersdorf : 205.419.49059 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Schwetzingen : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Wesel : 205.425.49001 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Wesel : 205.456.49002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Wiesbaden : Novartis Investigative site
A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device
Wiesbaden : 205.419.49053 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Witten : 205.419.49055 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Alexandroupolis : University General Hospital of Alexandroupolis
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Athens : Sotiria Chest hospital of Athens
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Heraklion Crete : University General Hospital of Heraklion
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Guatelama City : 205.418.50203 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Guatelmala city : 205.418.50204 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Guatelmala City : 205.418.50205 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Guatemala city : 205.418.50202 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Guatemala City : 205.418.50201 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Balassagyarmat : Dr. Kenessey Albert Kórház-Rendelöintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Balassagyarmat : Dr. Kenessey Albert Kórház-Rendelöintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Balassagyarmat : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Budapest : 205.425.36001 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Budapest : 205.425.36003 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
View More »
Budapest : 205.456.36005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Budapest : 205.444.36005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Debrecen : 205.456.36002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Debrecen : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Deszk : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Gyor : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Gyula : 205.456.36004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Miskolc : Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi O
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Miskolc : Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi O
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miskolc : 205.456.36001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Miskolc : 205.444.36001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Mosdos : 205.425.36002 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Mosdos : 205.444.36002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Mosonmagyarovar : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Mosonmagyaróvár : Karolina Kórház Rendelöintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Mosonmagyaróvár : Karolina Kórház Rendelöintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nyiregyhaza : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sopron : Sopron Megyei Jogú Város Erzsébet Kórház a DEOEC Oktató Kórh
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Sopron : Sopron Megyei Jogú Város Erzsébet Kórház a DEOEC Oktató Kórh
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Szeged : 205.425.36004 Boehringer Ingelheim Investigational Site
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
Szeged : Csongrád Megyei Önkormányzat Mellkasi Betegségek Szakkórháza Tüdőgondozó Intézet
Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma
Szigetbecse : 205.444.36004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Szigetvár : Micro Care Kft
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Tatabanya : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tatabánya : Komárom-Esztergom Megyei Önkormányzat Szent Borbála Kórháza
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Torokbalint : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Ahmedabad : Gujarat Pulmonary & Critical Care Clinic
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Ahmedabad : 205.419.91057 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Bangalore : Narayanan Hrudayalaya Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Bangalore : Chest and Maternity Centre
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Bangalore : M S Ramaiah Medical College & Teaching Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
View More »
Banglore : 205.418.91008 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Chennai : Chennai Thoracic Research Institute
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Chennai : 205.418.91005 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Chennai : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Coimbatore : 205.418.91004 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
